Collaborations (Tables)

12 Months Ended

Dec. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Change in Accounts Receivable, Contract Asset and Liabilities

The following table presents the changes in accounts receivable, contract assets and liabilities for the year ended December 31, 2024 (in thousands):

	Balance at December 31, 2023		Additions		Deductions			Balance at December 31, 2024
Accounts receivable and contract assets:
Billed receivables – Sanofi	$	15,000	$	8,812	$	(23,812	)	$	—
Unbilled receivables – Sanofi		3,762		5,997		(8,812	)		947
Total accounts receivable and contract assets	$	18,762	$	14,809	$	(32,624	)	$	947
Contract Liabilities:
Deferred Revenue – Sanofi		54,651		5,997		(47,072	)		13,576
Total contract liabilities	$	54,651	$	5,997	$	(47,072	)	$	13,576